Goal Directed Therapy (GDT) in hip replacement

Goal Directed Therapy (GDT) in hip replacement: a single-centre randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11616985

Enrollment

Registered

2011-03-18

Start date

2007-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary hip arthroplasty Musculoskeletal Diseases Primary hip arthroplasty

Interventions

All patients will receive spinal anaesthesia was performed at the L3-L4 level with levobupivacaine 0.5% 15 mg. CTRL group: Patients randomised to the control group will receive Ringer lactate sol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult (>18 years old), patients undergoing primary hip arthroplasty under spinal anaesthesia

Exclusion criteria

Exclusion criteria: 1. Patients refusing consent 2. Patients with planned admission to intensive care unit (ICU) postoperatively 3. Patients with a contraindication to spinal anaesthesia

Design outcomes

Primary

Measure	Time frame
1. Intraoperative fluid management -fluid management will be recorded from the arrival to the anaesthetic room until discharge to the ward 2. Blood consumption will be recorded from arrival to the anaesthetic room until hospital discharge	—

Secondary

Measure	Time frame
Postoperative morbidity: assessed from discharge to the ward until hospital discharge by a modified postoperative morbidity survey (POMS)	—

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026